John Pace
PFD Report
Partially Responded
Ref: 2023-0447
1 of 2 responded · Over 2 years old
Sent To
Response Status
Responses
1 of 2
56-Day Deadline
8 Jan 2024
Over 2 years old — no identified published response
About PFD responses
Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.
Source: Courts and Tribunals Judiciary
Coroner’s Concerns
The organisations responsible for the delivery of drug related services at HMP Chelmsford are Castle Rock Group (CRG) as the main contractor of health related services and Forward Trust as their sub-contractors for the drug treatment element of the service. One of the material issues in evidence was about changes in the discharge pathway for prisoners on methadone detoxification as well as those who decided to stop the detoxification programme before completion. CRG identified the need for this change in their Root Cause Analysis review and their live witnesses provided evidence that this new process is now being followed. Forward Trust provided evidence that this is the new process now embedded in their operating procedure. However, no documentary evidence of this new drug detoxification discharge pathway seems to exist, no protocols, no written procedures, no policy, no addendum to existing policies and procedures.
It is my concern that this new discharge pathway aimed at providing monitoring and support to prisoners who stop or complete the programme whilst in prison, has not been embedded in your organisations’ operating procedure and as such, there is a risk to prisoners in the future as compliance with the new discharge pathway and consistency of operations cannot be ensured.
It is my concern that this new discharge pathway aimed at providing monitoring and support to prisoners who stop or complete the programme whilst in prison, has not been embedded in your organisations’ operating procedure and as such, there is a risk to prisoners in the future as compliance with the new discharge pathway and consistency of operations cannot be ensured.
Responses
The Forward Trust has drafted and implemented a new 'Management of Non-engaging Service Users Protocol,' which has been published on their Intranet. They have also facilitated a dissemination and training programme for staff and added the protocol to relevant meeting agendas.
AI summary
View full response
Dear Dr Mellani
In response to your Regulation 28 notice dated 13/11/2023.
Re: Mr John Paul Pace deceased.
On 30/07/2020 The Coroner commenced an investigation into the death of Mr John Paul Pace. The investigation concluded at the end of the inquest on 25/10/2023.
The conclusion of the inquest was a short form conclusion of “Drug Related Death”.
CIRCUMSTANCES OF THE DEATH
On 29/11/2019, Mr John-Paul Pace was recalled to prison after being arrested for a drug related offence. He was sent to HMP Chelmsford. When he arrived at Chelmsford, Mr Pace tested positive for both opioids and cocaine. He was put on a drug detoxification programme and was prescribed methadone (an opiate substitute), which was progressively reduced over the following months. He was under the care of the GP to manage his depression and of the Integrated Drug Treatment Services to manage his drug use.
On 28/05/2020, Mr Pace stopped taking methadone, before he had completed the methadone reduction programme. He was prescribed medication to help with the expected withdrawal symptoms.
Shortly after 8.00am on 22/07/2020 Mr Pace was found unresponsive. An ambulance attended the prison and Mr Pace was certified dead at 8.16am.
• Mr Pace was serving a prison sentence at HMP Chelmsford for a drug related offence;
• Mr Pace was under the care of the Integrated Drug Treatment Service delivered by Forward Trust and was following a methadone detoxification programme;
• Mr Pace decided to stop methadone against medical advice before completing the detoxification programme;
• The post mortem examination concluded Mr Pace’s likely medical cause of death was “synthetic cannabinoid misuse”. The synthetic cannabinoid in question is known as “ ”.
The Forward Trust Registered Charity No. 1001701 Registered Company No. 2560474
The Forward Trust Unit 106, Edinburgh House 170 Kennington Lane, London SE11 5DP
CORONER’S CONCERNS The matters of concern identified in the notice are as follows.
‘The organisations responsible for the delivery of drug related services at HMP Chelmsford are Castle Rock Group (CRG) as the main contractor of health related services and Forward Trust as their sub-contractors for the drug treatment element of the service’.
‘One of the material issues in evidence was about changes in the discharge pathway for prisoners on methadone detoxification as well as those who decided to stop the detoxification programme before completion. CRG identified the need for this change in their Root Cause Analysis review and their live witnesses provided evidence that this new process is now being followed’.
‘Forward Trust provided evidence that this is the new process now embedded in their operating procedure. However, no documentary evidence of this new drug detoxification discharge pathway seems to exist, no protocols, no written procedures, no policy, no addendum to existing policies and procedures’.
‘It is my concern that this new discharge pathway aimed at providing monitoring and support to prisoners who stop or complete the programme whilst in prison, has not been embedded in your organisations’ operating procedure and as such, there is a risk to prisoners in the future as compliance with the new discharge pathway and consistency of operations cannot be ensured’.
SOURCES OF INFORMATION UTILISED
1. We have consulted with the witness bundle and had discussions with the , Head of Healthcare HMP Chelmsford.
2. I have had discussions with Forward Trust staff, (Head of Custodial Nursing Services) and
(Lead Nurse, HMP Chelmsford).
3. Reviewed the expert report dated 23/08/2021.
SUMMARY/RESPONSE
Following an internal audit of the relevant policies and procedures, we have now drafted and implemented a new protocol on the ‘Management of Non-engaging Service Users Protocol’ provided with our response.
The new protocol has now been published on the policy section of our Intranet. A dissemination and training programme has been facilitated using the matrix and Staff signatory documents contained within the appendices of the protocol. We have also added the protocol to the Clinical Governance, Managers and Staff meeting agendas.
The Forward Trust Registered Charity No. 1001701 Registered Company No. 2560474
The Forward Trust Unit 106, Edinburgh House 170 Kennington Lane, London SE11 5DP
Finally the Forward Trust prides itself on providing evidence based best practice to the most vulnerable and marginalized in society. We are committed to supporting our partners in delivering coordinated care for our patients. We readily welcome any Coroner’s observations and directions to continually improve our services.
In response to your Regulation 28 notice dated 13/11/2023.
Re: Mr John Paul Pace deceased.
On 30/07/2020 The Coroner commenced an investigation into the death of Mr John Paul Pace. The investigation concluded at the end of the inquest on 25/10/2023.
The conclusion of the inquest was a short form conclusion of “Drug Related Death”.
CIRCUMSTANCES OF THE DEATH
On 29/11/2019, Mr John-Paul Pace was recalled to prison after being arrested for a drug related offence. He was sent to HMP Chelmsford. When he arrived at Chelmsford, Mr Pace tested positive for both opioids and cocaine. He was put on a drug detoxification programme and was prescribed methadone (an opiate substitute), which was progressively reduced over the following months. He was under the care of the GP to manage his depression and of the Integrated Drug Treatment Services to manage his drug use.
On 28/05/2020, Mr Pace stopped taking methadone, before he had completed the methadone reduction programme. He was prescribed medication to help with the expected withdrawal symptoms.
Shortly after 8.00am on 22/07/2020 Mr Pace was found unresponsive. An ambulance attended the prison and Mr Pace was certified dead at 8.16am.
• Mr Pace was serving a prison sentence at HMP Chelmsford for a drug related offence;
• Mr Pace was under the care of the Integrated Drug Treatment Service delivered by Forward Trust and was following a methadone detoxification programme;
• Mr Pace decided to stop methadone against medical advice before completing the detoxification programme;
• The post mortem examination concluded Mr Pace’s likely medical cause of death was “synthetic cannabinoid misuse”. The synthetic cannabinoid in question is known as “ ”.
The Forward Trust Registered Charity No. 1001701 Registered Company No. 2560474
The Forward Trust Unit 106, Edinburgh House 170 Kennington Lane, London SE11 5DP
CORONER’S CONCERNS The matters of concern identified in the notice are as follows.
‘The organisations responsible for the delivery of drug related services at HMP Chelmsford are Castle Rock Group (CRG) as the main contractor of health related services and Forward Trust as their sub-contractors for the drug treatment element of the service’.
‘One of the material issues in evidence was about changes in the discharge pathway for prisoners on methadone detoxification as well as those who decided to stop the detoxification programme before completion. CRG identified the need for this change in their Root Cause Analysis review and their live witnesses provided evidence that this new process is now being followed’.
‘Forward Trust provided evidence that this is the new process now embedded in their operating procedure. However, no documentary evidence of this new drug detoxification discharge pathway seems to exist, no protocols, no written procedures, no policy, no addendum to existing policies and procedures’.
‘It is my concern that this new discharge pathway aimed at providing monitoring and support to prisoners who stop or complete the programme whilst in prison, has not been embedded in your organisations’ operating procedure and as such, there is a risk to prisoners in the future as compliance with the new discharge pathway and consistency of operations cannot be ensured’.
SOURCES OF INFORMATION UTILISED
1. We have consulted with the witness bundle and had discussions with the , Head of Healthcare HMP Chelmsford.
2. I have had discussions with Forward Trust staff, (Head of Custodial Nursing Services) and
(Lead Nurse, HMP Chelmsford).
3. Reviewed the expert report dated 23/08/2021.
SUMMARY/RESPONSE
Following an internal audit of the relevant policies and procedures, we have now drafted and implemented a new protocol on the ‘Management of Non-engaging Service Users Protocol’ provided with our response.
The new protocol has now been published on the policy section of our Intranet. A dissemination and training programme has been facilitated using the matrix and Staff signatory documents contained within the appendices of the protocol. We have also added the protocol to the Clinical Governance, Managers and Staff meeting agendas.
The Forward Trust Registered Charity No. 1001701 Registered Company No. 2560474
The Forward Trust Unit 106, Edinburgh House 170 Kennington Lane, London SE11 5DP
Finally the Forward Trust prides itself on providing evidence based best practice to the most vulnerable and marginalized in society. We are committed to supporting our partners in delivering coordinated care for our patients. We readily welcome any Coroner’s observations and directions to continually improve our services.
Report Sections
Investigation and Inquest
On 30 July 2020 I commenced an investigation into the death of Mr John Paul Pace. The investigation concluded at the end of the inquest on 25 October 2023.
The conclusion of the inquest was a short form conclusion of “Drug Related Death”. On 29 November 2019, Mr John-Paul Pace was recalled to prison after being arrested for a drug related offence. He was sent to HMP Chelmsford. When he arrived at Chelmsford, Mr Pace tested positive for both opioids and . He was put on a drug detoxification programme and was prescribed methadone (an opiate substitute), which was progressively reduced over the following months. He was under the care of the GP to manage his depression and of the Integrated Drug Treatment Services to manage his drug use. On 28 May 2020, Mr Pace stopped taking methadone, before he had completed the methadone reduction programme. He was prescribed medication to help with the expected withdrawal symptoms. Shortly after 8.00am on 22 July 2020 Mr Pace was found unresponsive. An ambulance attended the prison and Mr Pace was certified dead at 8.16am.
The conclusion of the inquest was a short form conclusion of “Drug Related Death”. On 29 November 2019, Mr John-Paul Pace was recalled to prison after being arrested for a drug related offence. He was sent to HMP Chelmsford. When he arrived at Chelmsford, Mr Pace tested positive for both opioids and . He was put on a drug detoxification programme and was prescribed methadone (an opiate substitute), which was progressively reduced over the following months. He was under the care of the GP to manage his depression and of the Integrated Drug Treatment Services to manage his drug use. On 28 May 2020, Mr Pace stopped taking methadone, before he had completed the methadone reduction programme. He was prescribed medication to help with the expected withdrawal symptoms. Shortly after 8.00am on 22 July 2020 Mr Pace was found unresponsive. An ambulance attended the prison and Mr Pace was certified dead at 8.16am.
Circumstances of the Death
• Mr Pace was serving a prison sentence at HMP Chelmsford for a drug related offence;
• Mr Pace was under the care of the Integrated Drug Treatment Service delivered by Forward Trust and was following a methadone detoxification programme;
• Mr Pace decided to stop methadone against medical advice before completing the detoxification programme;
• The post mortem examination concluded Mr Pace’s likely medical cause of death was “synthetic cannabinoid misuse”. The synthetic cannabinoid in question is known as “ ”.
• Mr Pace was under the care of the Integrated Drug Treatment Service delivered by Forward Trust and was following a methadone detoxification programme;
• Mr Pace decided to stop methadone against medical advice before completing the detoxification programme;
• The post mortem examination concluded Mr Pace’s likely medical cause of death was “synthetic cannabinoid misuse”. The synthetic cannabinoid in question is known as “ ”.
Similar PFD Reports
Reports sharing organisations, categories, or themes with this PFD
Related Inquiry Recommendations
Public inquiry recommendations addressing similar themes
Prevent discharge of hospitalised children with concerns until home is safe
Laming Inquiry
Care and discharge planning
Require consultant or paediatrician permission for discharging children with protection concerns.
Laming Inquiry
Care and discharge planning
Require documented future care plan for discharging children with protection concerns.
Laming Inquiry
Care and discharge planning
Ensure identified GP for children with deliberate harm concerns discharged from hospital.
Laming Inquiry
Care and discharge planning
Establish comprehensive counselling and support services as integral to patient care
Bristol Heart Inquiry
Care and discharge planning
Require every trust to provide a professional bereavement service and online information
Bristol Heart Inquiry
Care and discharge planning
Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.